Eli Lilly Corp. buy Truist Financial Co.
Start price
29.11.23
/
50%
€540.50
Target price
29.11.24
€591.57
Performance (%)
50.10%
Price
04.10.24
€807.70
Summary
This prediction is currently active. With a performance of 50.10% the BUY prediction by Truist_Financial_Co_ is a big success. Dividends of €3.59 are taken into consideration when calculating the performance. This prediction currently runs until 29.11.24. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Eli Lilly Corp. | 2.787% | 2.787% |
iShares Core DAX® | -1.114% | 3.430% |
iShares Nasdaq 100 | 1.816% | 6.911% |
iShares Nikkei 225® | 2.113% | 5.501% |
iShares S&P 500 | 2.038% | 5.327% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE: LLY) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $650.00 price target on the stock.
Ratings data for LLY provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€837.30
25.06.24
25.06.24
€934.00
25.06.25
25.06.25
-3.39%
04.10.24
04.10.24
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€726.70
01.05.24
01.05.24
€834.73
01.05.25
01.05.25
11.47%
04.10.24
04.10.24
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€714.00
22.03.24
22.03.24
€786.51
22.03.25
22.03.25
13.46%
04.10.24
04.10.24
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€678.50
07.02.24
07.02.24
€788.80
07.02.25
07.02.25
19.57%
04.10.24
04.10.24